Revision Total Hip Arthroplasty in Osteogenesis Imperfecta

Abstract

Osteogenesis imperfecta (OI) is a rare group of connective tissue disorders commonly associated with bone fragility, deformity, and fractures, leading to instability and early osteoarthritis. Current advancements in the medical and surgical management of OI have extended the life span of these patients, resulting in an increased need for joint arthroplasty to help maintain quality of life. However, surgery among this patient population is technically challenging and comes with a high burden of revision. In this report, we present a case of revision total hip arthroplasty in a patient with OI and review important considerations to help ensure proper preoperative planning and correct precautions to minimize complications and decrease implant failure.

Keywords

osteogenesis imperfecta - revision hip arthroplasty - bone fragility - complex total hip arthroplasty

• References

• 1 Tosi LL, Oetgen ME, Floor MK. , et al. Initial report of the osteogenesis imperfecta adult natural history initiative. Orphanet J Rare Dis 2015; 10 (01) 146
• 2 Forlino A, Cabral WA, Barnes AM, Marini JC. New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol 2011; 7 (09) 540-557
• 3 Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet 2004; 363 (9418): 1377-1385
• 4 Singer RB, Ogston SA, Paterson CR. Mortality in various types of osteogenesis imperfecta. J Insur Med 2001; 33 (03) 216-220
• 5 Paterson CR, Ogston SA, Henry RM. Life expectancy in osteogenesis imperfecta. BMJ 1996; 312 (7027): 351
• 6 Palomo T, Vilaça T, Lazaretti-Castro M. Osteogenesis imperfecta: diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes 2017; 24 (06) 381-388
• 7 Papagelopoulos PJ, Morrey BF. Hip and knee replacement in osteogenesis imperfecta. J Bone Joint Surg Am 1993; 75 (04) 572-580
• 8 Marini JC, Forlino A, Bächinger HP. , et al. Osteogenesis imperfecta. Nat Rev Dis Primers 2017; 3: 17052
• 9 Stevenson DA, Carey JC, Byrne JLB, Srisukhumbowornchai S, Feldkamp ML. Analysis of skeletal dysplasias in the Utah population. Am J Med Genet A 2012; 158A [phone]
• 10 Moffitt KB, Abiri OO, Scheuerle AE, Langlois PH. Descriptive epidemiology of selected heritable birth defects in Texas. Birth Defects Res A Clin Mol Teratol 2011; 91 (12) 990-994
• 11 Krishnan H, Patel NK, Skinner JA. , et al. Primary and revision total hip arthroplasty in osteogenesis imperfecta. Hip Int 2013; 23 (03) 303-309
• 12 Roberts TT, Cepela DJ, Uhl RL, Lozman J. Orthopaedic considerations for the adult with osteogenesis imperfecta. J Am Acad Orthop Surg 2016; 24 (05) 298-308
• 13 King JD, Bobechko WP. Osteogenesis imperfecta: an orthopaedic description and surgical review. J Bone Jt Surg 1971; 53B (01) 72-89
• 14 Ahn J, Carter E, Raggio CL, Green DW. Acetabular protrusio in patients with osteogenesis imperfecta: risk factors and progression. J Pediatr Orthop 2017 (e-pub ahead of print). Doi: 10.1097/bpo.0000000000001051
• 15 McBride MT, Muldoon MP, Santore RF, Trousdale RT, Wenger DR. Protrusio acetabuli: diagnosis and treatment. J Am Acad Orthop Surg 2001; 9 (02) 79-88
• 16 Mullaji AB, Shetty GM. Acetabular protrusio: surgical technique of dealing with a problem in depth. Bone Joint J 2013; 95-B (11, Suppl A ): 37-40
• 17 Davidson D, Pike J, Garbuz D, Duncan CP, Masri BA. Intraoperative periprosthetic fractures during total hip arthroplasty. Evaluation and management. J Bone Joint Surg Am 2008; 90 (09) 2000-2012
• 18 Berry DJ. Epidemiology: hip and knee. Orthop Clin North Am 1999; 30 (02) 183-190
• 19 Bottai V, Dell'Osso G, Celli F. , et al. Total hip replacement in osteoarthritis: the role of bone metabolism and its complications. Clin Cases Miner Bone Metab 2015; 12 (03) 247-250
• 20 Mäkelä KT, Eskelinen A, Pulkkinen P, Paavolainen P, Remes V. Total hip arthroplasty for primary osteoarthritis in patients fifty-five years of age or older. An analysis of the Finnish arthroplasty registry. J Bone Joint Surg Am 2008; 90 (10) 2160-2170
• 21 Sandiford NA, Garbuz DS, Masri BA, Duncan CP. Nonmodular tapered fluted titanium stems osseointegrate reliably at short term in revision THAs. Clin Orthop Relat Res 2017; 475 (01) 186-192
• 22 Huang Y, Shao H, Zhou Y, Gu J, Tang H, Yang D. Femoral bone remodeling in revision total hip arthroplasty with use of modular compared with monoblock tapered fluted titanium stems: the role of stem length and stiffness. J Bone Joint Surg Am 2019; 101 (06) 531-538
• 23 Weeden SH, Paprosky WG. Minimal 11-year follow-up of extensively porous-coated stems in femoral revision total hip arthroplasty. J Arthroplasty 2002; 17 (04) (Suppl. 01) 134-137
• 24 Herry Y, Viste A, Bothorel H, Desmarchelier R, Fessy MH. Long-term survivorship of a monoblock long cementless stem in revision total hip arthroplasty. Int Orthop 2019; 43 (10) 2279-2284
• 25 Biggin A, Munns CF. Long-term bisphosphonate therapy in osteogenesis imperfecta. Curr Osteoporos Rep 2017; 15 (05) 412-418
• 26 Dwan K, Phillipi CA, Steiner RD, Basel D. Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev 2014; (07) CD005088
• 27 Lozano-Calderon SA, Colman MW, Raskin KA, Hornicek FJ, Gebhardt M. Use of bisphosphonates in orthopedic surgery: pearls and pitfalls. Orthop Clin North Am 2014; 45 (03) 403-416
• 28 Cavalli L, Brandi ML. Periprosthetic bone loss: diagnostic and therapeutic approaches. F1000 Res 2014; 2: 266
• 29 Muratore M, Quarta E, Quarta L. , et al. Ibandronate and cementless total hip arthroplasty: densitometric measurement of periprosthetic bone mass and new therapeutic approach to the prevention of aseptic loosening. Clin Cases Miner Bone Metab 2012; 9 (01) 50-55
• 30 Bhandari M, Bajammal S, Guyatt GH. , et al. Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis. J Bone Joint Surg Am 2005; 87 (02) 293-301
• 31 Prieto-Alhambra D, Lalmohamed A, Abrahamsen B. , et al. Oral bisphosphonate use and total knee/hip implant survival: validation of results in an external population-based cohort. Arthritis Rheumatol 2014; 66 (11) 3233-3240
• 32 Prieto-Alhambra D, Javaid MK, Judge A. , et al. Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use. Arthritis Rheum 2011; 63 (04) 992-1001
• 33 Prieto-Alhambra D, Kassim Javaid M, Judge A. , et al. Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. BMJ 2012; 343: d7222
• 34 Lin T, Yan SG, Cai XZ, Ying ZM. Bisphosphonates for periprosthetic bone loss after joint arthroplasty: a meta-analysis of 14 randomized controlled trials. Osteoporos Int 2012; 23 (06) 1823-1834
• 35 Khatod M, Inacio MCS, Dell RM, Bini SA, Paxton EW, Namba RS. Association of bisphosphonate use and risk of revision after THA: outcomes from a US Total Joint Replacement Registry. Clin Orthop Relat Res 2015; 473 (11) 3412-3420
• 36 Teng S, Yi C, Krettek C, Jagodzinski M. Bisphosphonate use and risk of implant revision after total hip/knee arthroplasty: a meta-analysis of observational studies. PLoS One 2015; 10 (10) e0139927
• 37 Desai PA, Vyas PA, Lane JM. Atypical femoral fractures: a review of the literature. Curr Osteoporos Rep 2013; 11 (03) 179-187